Consensus Stryker Corporation

Stocks

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 16:00:02 2026-09-25 EDT			5-day change	1st Jan Change
272.36 ^USD	+0.97%		-1.00%	-22.51%

09-23	US companies face rise in cyber attacks	RE
09-22	TD Cowen Adjusts Price Target on Stryker to $298 From $355, Keeps Hold Rating	MT

Evolution of the Average Target: Stryker Corporation

Evolution of the Target Price: Stryker Corporation

Changes in Analyst Recommendations: Stryker Corporation

c54.gtHk-D4Rg5u8b4ccTLwFcaC8CfTORV1uqKv2cIIF18I.w5q-wXNl1qzRHuxqPIxEI5fleKSUFhUJxtG4QvdP-qvQsK6JUHjhzP4lxg~7150e1f25f34cf6b84098a0e204e5fd2

Analysts' recommendations: Stryker Corporation

09-22	TD Cowen Adjusts Price Target on Stryker to $298 From $355, Keeps Hold Rating	MT
09-22	Jefferies Adjusts Price Target on Stryker to $405 From $440, Keeps Buy Rating	MT
09-21	Raymond James Adjusts Price Target on Stryker to $330 From $370, Keeps Outperform Rating	MT
09-18	Canaccord Genuity Adjusts Price Target on Stryker to $385 From $400, Keeps Buy Rating	MT
09-17	Stryker Facing Promising Setup Next Year, Trading Upside Limited in 2026, RBC Says	MT
09-14	Bernstein Adjusts Price Target on Stryker to $385 From $420, Keeps Outperform Rating	MT
09-09	Citigroup Adjusts Stryker Price Target to $360 From $399, Maintains Buy Rating	MT
09-09	Wells Fargo Adjusts Price Target on Stryker to $348 From $418, Keeps Overweight Rating	MT
09-09	BMO Capital Adjusts Price Target on Stryker to $317 From $369, Keeps Outperform Rating	MT
08-18	Leerink Partners Adjusts Price Target on Stryker to $403 From $407, Maintains Outperform Rating	MT
08-13	Citigroup Adjusts Price Target on Stryker to $399 From $385, Maintains Buy Rating	MT
08-05	Rothschild & Co Redburn Adjusts Stryker Price Target to $360 From $346	MT
08-03	UBS Adjusts Stryker Price Target to $382 From $400, Maintains Buy Rating	MT
08-03	Analyst recommendations: Chevron, Linde, RTX, Colgate-Palmolive, American Electric Power...
07-31	RBC Cuts Price Target on Stryker to $420 From $435, Keeps Outperform Rating	MT
07-31	Evercore ISI Adjusts Stryker Price Target to $355 From $350, Maintains Outperform Rating	MT
07-31	Truist Lifts Price Target on Stryker to $340 From $330, Keeps Hold Rating	MT
07-31	Raymond James Adjusts Price Target on Stryker to $370 From $383, Maintains Outperform Rating	MT
07-31	Jefferies Adjusts Price Target on Stryker to $440 From $455, Maintains Buy Rating	MT
07-31	BTIG Adjusts Price Target on Stryker to $358 From $371, Maintains Buy Rating	MT
07-31	Piper Sandler Adjusts Price Target on Stryker to $390 From $420, Maintains Overweight Rating	MT
07-31	JPMorgan Adjusts Price Target on Stryker to $350 From $400, Maintains Overweight Rating	MT
07-31	Bernstein Adjusts Price Target on Stryker to $420 From $410, Maintains Outperform Rating	MT
07-30	The Fed Gets a Better Inflation Number
07-28	UBS Upgrades Stryker to Buy From Neutral, Adjusts Price Target to $400 From $380	MT

More recommendations

Medical Devices & Implants

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
STRYKER CORPORATION			+35.48%
SMITH & NEPHEW PLC			+27%
GLAUKOS CORPORATION			+28.66%
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.			+44.59%
DOUBLE MEDICAL TECHNOLOGY INC.	-	-	+25.79%
INSPIRE MEDICAL SYSTEMS, INC.			-10.92%
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.			+49.69%
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-	-	-
Average			+28.61%
Weighted average by Cap.			+33.88%